selected publications
-
article
- Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven years. Arthritis %26 rheumatology (Hoboken, N.J.). 67:2759-2770. 2015-01-01